Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study (Q73292530)
Jump to navigation
Jump to search
scientific article published on 01 May 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study |
scientific article published on 01 May 1997 |
Statements
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study (English)
Appelbaum FR
1 reference
Leith CP
Kopecky KJ
Godwin J
McConnell T
Slovak ML
Chen IM